AsiaIPEX is a one-stop-shop for players in the IP industry, facilitating IP trade and connection to the IP world. Whether you are a patent owner interested in selling your IP, or a manufacturer looking to buy technologies to upgrade your operation, you will find the portal a useful resource.

Back to search results

Substituted quinolone carboxylic acids and potential therapeutic effects in CNS disorders

Technology Benefits

- The compounds are highly selective for GABA sub A receptor. - The compounds binds to a unique site on GABA sub A receptor.

Technology Application

Treatment of CNS disorders related to the modulation of GRC.

Detailed Technology Description

GABA sub A receptor complex (GRC) is ubiquitously expressed throughout the CNS with almost all neurons staining for their presence. It provides majority of the fast inhibitory synaptic transmission regulations. It is well-documented that modulation of the GRC can ameliorate anxiety, seizure activity, and insomnia. However, none of the known drugs are selectively modulate GRC without sides effects. Researchers at UCI invented substituted quinolone carboxylic acids and their derivatives that bind to GRC at a unique site. The compounds can be used potentially to treat and/or prevent a variety of CNS disorders related to abnormal activities of GRC. Such diseases could be acute and chronic pain, depression and bipolar disorder, etc.

Application No.

7355047

Others

State Of Development

The compounds has been tested in animals studies.

Tech ID/UC Case

24922/2002-440-0

Related Cases

2002-440-0

Country/Region

USA

For more information, please click Here